CMLF CM Life Sciences, Inc. - Class A
Blank check.
On 2/10/2021 the company announced a pending merger with Mount Sinai Genomics, Inc. d/b/a Sema4 an AI-driven patient-centered genomic and clinical data insight platform company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease.
$18.05 -1.71 (-8.63%)
As of 03/03/2021 15:47:55 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Financials
Shell Companies
USA
10/26/2020
44,275,000
3,410,655
$874,431,250
0.00%
SEC Edgar Online
10-Q
10-K
18978W109
Common stocks
Small cap
Financials
Shell Companies
USA
10/26/2020
44,275,000
3,410,655
$874,431,250
0.00%
SEC Edgar Online
10-Q
10-K
18978W109
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
0.00
0.00
0.00%
0.00%
0.00
0.00
0.00%
0.00%